Key Product Details

Species Reactivity

Validated:

Human

Cited:

Human, Mouse

Applications

Validated:

Western Blot, Immunocytochemistry

Cited:

Western Blot, Flow Cytometry, Immunocytochemistry

Label

Unconjugated

Antibody Source

Polyclonal Goat IgG
View all IFITM1 Primary Antibodies »

Product Specifications

Immunogen

E. coli-derived recombinant human IFITM1
Met1-His36
Accession # NP_003632

Specificity

Detects human IFITM1 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 40% cross-reactivity with recombinant human (rh) IFITM2 and rhIFITM3 is observed.

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Scientific Data Images for Human IFITM1 Antibody

Detection of Human IFITM1 antibody by Western Blot.

Detection of Human IFITM1 by Western Blot.

Western blot shows lysates of Jurkat human acute T cell leukemia cell line, TF-1 human erythroleukemic cell line, human placenta tissue. PVDF membrane was probed with 1 µg/mL of Goat Anti-Human IFITM1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF4827) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF019). A specific band was detected for IFITM1 at approximately 17 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 8.

IFITM1 antibody in K562 Human Cell Line by Immunocytochemistry (ICC).

IFITM1 in K562 Human Cell Line.

IFITM1 was detected in immersion fixed K562 human chronic myelogenous leukemia cell line using Goat Anti-Human IFITM1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF4827) at 1.7 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Goat IgG Secondary Antibody (red; Catalog # NL001) and counterstained with DAPI (blue). Specific staining was localized to plasma membranes and cytoplasm. View our protocol for Fluorescent ICC Staining of Non-adherent Cells.

Detection of IFITM1 by Western Blot

Detection of IFITM1 by Western Blot

IFITM1/2/3 triple knockout enhances KSHV and RRV infection in A549 cells and HFF. A549 cells (A), HFF (B), and HUVEC (C) were transduced with lentiviral vectors encoding Cas9 and the sgRNAs shown in Fig. 2. (A to C, left panels) IFITM knockout (sgIFITM1/2/3-a, sgIFITM1/2/3-b) or control (sgNT-a, sgNT-b) cells treated with IFN-alpha (5,000 U/ml) or H2O (control) and infected with KSHV-GFP, RRV-YFP, IAV lentiviral pseudotype (IAV-LP), or MLV lentiviral pseudotype (MLV-LP). Infection was measured using flow cytometry to detect expression of the fluorescent reporter gene. The graph shows individual data points representing averaged values for GFP+/YFP+ cells of either two nontargeting (sgNT-a, sgNT-b) or IFITM1/2/3 knockout (sgIFITM1/2/3-a, sgIFITM1/2/3-b) transduced cells and floating bars representing the mean averaged from results of four independent experiments for A549 cells and HFF (A and B) and three independent experiments for HUVEC (C). Infections for each single experiment were performed in triplicate for each condition. Data points from the same experiment are labeled with identical symbols. The different sgRNAs were treated as biological replicates within each experiment. Statistical significance was determined by two‐way analysis of variance (ANOVA), and P values were corrected for all possible multiple comparisons within one family by Tukey’s method (nonsignificant [ns], P > 0.05; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001). (A to C, right panels) Representative Western blots of IFITM knockout (sgIFITM1/2/3-a or sgIFITM1/2/3-b) or control (sgNT-a or sgNT-b) cells treated with IFN-alpha (5,000 U/ml) or H2O. Indicated IFITM expression was detected with antibodies shown in Fig. 1A; GAPDH served as a loading control. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34933450), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IFITM1 by Western Blot

Detection of IFITM1 by Western Blot

KSHV induces IFITM1, IFITM2, and IFITM3 expression in A549 cells. (A) Western blot of 293T cells transduced with pQCXIP constructs to express IFITM1 to -3 or pQCXIP (empty vector). IFITMs were detected using the respective IFITM antibody, and GAPDH served as a loading control. (B and C) Fluorescence microscopy images (scale bar, 200 μm) (B) and Western blot analysis (C) of A549 cells infected with KSHV-GFP or RRV-YFP or treated with H2O or IFN-alpha (5,000 U/ml) for the indicated time and harvested using SDS sample buffer. IFITM expression was detected with antibodies shown in panel A. MxA served as control for IFN-stimulated gene induction; GAPDH served as a loading control. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34933450), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IFITM1 by Western Blot

Detection of IFITM1 by Western Blot

Overexpression of IFITM1 inhibits KSHV and RRV infection in a cell-specific manner. A549 cells (A), HFF (B), 293T cells (C), and SLK cells (D) were transduced with pQCXIP constructs to express IFITM1-3 or pQCXIP (empty vector). (A to D, left panels) IFITM-overexpressing cells were infected with KSHV-GFP, RRV-YFP, IAV lentiviral pseudotype (IAV-LP), or MLV lentiviral pseudotype (MLV-LP). Infection was measured using flow cytometry to detect expression of the fluorescent reporter genes. The data show values normalized to pQCXIP empty vector, which was set to 100%, and the error bars represent the standard error of the mean of results of four independent experiments, each performed in triplicate. Statistical significance was determined by ordinary two-way ANOVA, and P values were corrected for multiple comparisons by Dunnett’s method (ns, P > 0.05; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001). (A to C, right panels) Representative Western blots of IFITM-overexpressing cells. Expression of myc-tagged IFITMs was determined using anti-myc antibody; GAPDH served as a loading control. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34933450), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IFITM1 by Western Blot

Detection of IFITM1 by Western Blot

Overexpression of IFITM1 inhibits KSHV and RRV infection in a cell-specific manner. A549 cells (A), HFF (B), 293T cells (C), and SLK cells (D) were transduced with pQCXIP constructs to express IFITM1-3 or pQCXIP (empty vector). (A to D, left panels) IFITM-overexpressing cells were infected with KSHV-GFP, RRV-YFP, IAV lentiviral pseudotype (IAV-LP), or MLV lentiviral pseudotype (MLV-LP). Infection was measured using flow cytometry to detect expression of the fluorescent reporter genes. The data show values normalized to pQCXIP empty vector, which was set to 100%, and the error bars represent the standard error of the mean of results of four independent experiments, each performed in triplicate. Statistical significance was determined by ordinary two-way ANOVA, and P values were corrected for multiple comparisons by Dunnett’s method (ns, P > 0.05; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001). (A to C, right panels) Representative Western blots of IFITM-overexpressing cells. Expression of myc-tagged IFITMs was determined using anti-myc antibody; GAPDH served as a loading control. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34933450), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IFITM1 by Western Blot

Detection of IFITM1 by Western Blot

IFITM1/2/3 triple knockout enhances KSHV and RRV infection in A549 cells and HFF. A549 cells (A), HFF (B), and HUVEC (C) were transduced with lentiviral vectors encoding Cas9 and the sgRNAs shown in Fig. 2. (A to C, left panels) IFITM knockout (sgIFITM1/2/3-a, sgIFITM1/2/3-b) or control (sgNT-a, sgNT-b) cells treated with IFN-alpha (5,000 U/ml) or H2O (control) and infected with KSHV-GFP, RRV-YFP, IAV lentiviral pseudotype (IAV-LP), or MLV lentiviral pseudotype (MLV-LP). Infection was measured using flow cytometry to detect expression of the fluorescent reporter gene. The graph shows individual data points representing averaged values for GFP+/YFP+ cells of either two nontargeting (sgNT-a, sgNT-b) or IFITM1/2/3 knockout (sgIFITM1/2/3-a, sgIFITM1/2/3-b) transduced cells and floating bars representing the mean averaged from results of four independent experiments for A549 cells and HFF (A and B) and three independent experiments for HUVEC (C). Infections for each single experiment were performed in triplicate for each condition. Data points from the same experiment are labeled with identical symbols. The different sgRNAs were treated as biological replicates within each experiment. Statistical significance was determined by two‐way analysis of variance (ANOVA), and P values were corrected for all possible multiple comparisons within one family by Tukey’s method (nonsignificant [ns], P > 0.05; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001). (A to C, right panels) Representative Western blots of IFITM knockout (sgIFITM1/2/3-a or sgIFITM1/2/3-b) or control (sgNT-a or sgNT-b) cells treated with IFN-alpha (5,000 U/ml) or H2O. Indicated IFITM expression was detected with antibodies shown in Fig. 1A; GAPDH served as a loading control. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34933450), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IFITM1 by Western Blot

Detection of IFITM1 by Western Blot

IFITM1/2/3 triple knockout enhances KSHV and RRV infection in A549 cells and HFF. A549 cells (A), HFF (B), and HUVEC (C) were transduced with lentiviral vectors encoding Cas9 and the sgRNAs shown in Fig. 2. (A to C, left panels) IFITM knockout (sgIFITM1/2/3-a, sgIFITM1/2/3-b) or control (sgNT-a, sgNT-b) cells treated with IFN-alpha (5,000 U/ml) or H2O (control) and infected with KSHV-GFP, RRV-YFP, IAV lentiviral pseudotype (IAV-LP), or MLV lentiviral pseudotype (MLV-LP). Infection was measured using flow cytometry to detect expression of the fluorescent reporter gene. The graph shows individual data points representing averaged values for GFP+/YFP+ cells of either two nontargeting (sgNT-a, sgNT-b) or IFITM1/2/3 knockout (sgIFITM1/2/3-a, sgIFITM1/2/3-b) transduced cells and floating bars representing the mean averaged from results of four independent experiments for A549 cells and HFF (A and B) and three independent experiments for HUVEC (C). Infections for each single experiment were performed in triplicate for each condition. Data points from the same experiment are labeled with identical symbols. The different sgRNAs were treated as biological replicates within each experiment. Statistical significance was determined by two‐way analysis of variance (ANOVA), and P values were corrected for all possible multiple comparisons within one family by Tukey’s method (nonsignificant [ns], P > 0.05; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001). (A to C, right panels) Representative Western blots of IFITM knockout (sgIFITM1/2/3-a or sgIFITM1/2/3-b) or control (sgNT-a or sgNT-b) cells treated with IFN-alpha (5,000 U/ml) or H2O. Indicated IFITM expression was detected with antibodies shown in Fig. 1A; GAPDH served as a loading control. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34933450), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IFITM1 by Western Blot

Detection of IFITM1 by Western Blot

KSHV induces IFITM1, IFITM2, and IFITM3 expression in A549 cells. (A) Western blot of 293T cells transduced with pQCXIP constructs to express IFITM1 to -3 or pQCXIP (empty vector). IFITMs were detected using the respective IFITM antibody, and GAPDH served as a loading control. (B and C) Fluorescence microscopy images (scale bar, 200 μm) (B) and Western blot analysis (C) of A549 cells infected with KSHV-GFP or RRV-YFP or treated with H2O or IFN-alpha (5,000 U/ml) for the indicated time and harvested using SDS sample buffer. IFITM expression was detected with antibodies shown in panel A. MxA served as control for IFN-stimulated gene induction; GAPDH served as a loading control. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34933450), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IFITM1 by Western Blot

Detection of IFITM1 by Western Blot

Overexpression of IFITM1 inhibits KSHV and RRV infection in a cell-specific manner. A549 cells (A), HFF (B), 293T cells (C), and SLK cells (D) were transduced with pQCXIP constructs to express IFITM1-3 or pQCXIP (empty vector). (A to D, left panels) IFITM-overexpressing cells were infected with KSHV-GFP, RRV-YFP, IAV lentiviral pseudotype (IAV-LP), or MLV lentiviral pseudotype (MLV-LP). Infection was measured using flow cytometry to detect expression of the fluorescent reporter genes. The data show values normalized to pQCXIP empty vector, which was set to 100%, and the error bars represent the standard error of the mean of results of four independent experiments, each performed in triplicate. Statistical significance was determined by ordinary two-way ANOVA, and P values were corrected for multiple comparisons by Dunnett’s method (ns, P > 0.05; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001). (A to C, right panels) Representative Western blots of IFITM-overexpressing cells. Expression of myc-tagged IFITMs was determined using anti-myc antibody; GAPDH served as a loading control. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34933450), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Human IFITM1 Antibody

Application
Recommended Usage

Immunocytochemistry

5-15 µg/mL
Sample: Immersion fixed K562 human chronic myelogenous leukemia cell line

Western Blot

1 µg/mL
Sample: Jurkat human acute T cell leukemia cell line, TF‑1 human erythroleukemic cell line, human placenta tissue

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: IFITM1

IFITM1 (Interferon inducible transmembrane protein 1; also Leu13, CD225 and "9‑27") is a 17 kDa member of the CD225 family of proteins. It is inducible in multiple cell types by both type I and II interferons, and although reported to occur on the cell surface, is apparently concentrated in the ER. Homotypic IFITM1 interactions promote p53 antiproliferative activity by blocking p53 phosphorylation on Thr55. Human IFITM1 is a 2‑transmembrane protein 125 amino acids (aa) in length. The topology of the molecule is unclear, but transmembrane segments are reported between aa 37‑57 and 87‑107. Over aa 1‑36, human IFITM1 shares only 47% aa identity with mouse IFITM1.

Long Name

Interferon-induced Transmembrane Protein 1

Alternate Names

CD225, IFI17, Leu-13

Entrez Gene IDs

8519 (Human); 293618 (Rat)

Gene Symbol

IFITM1

UniProt

NP_003632

Additional IFITM1 Products

Product Documents for Human IFITM1 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Human IFITM1 Antibody

For research use only

Related Research Areas

Primordial and Mature Germ Cells

Citations for Human IFITM1 Antibody

Customer Reviews for Human IFITM1 Antibody

There are currently no reviews for this product. Be the first to review Human IFITM1 Antibody and earn rewards!

Have you used Human IFITM1 Antibody?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs

No product specific FAQs exist for this product.

View all FAQs for Antibodies